Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Jose Miguel Vela"'
Autor:
Caterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Nanna Brix Finnerup, Luis Garcia-Larrea, Tom Li, Marcus Goetz, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Irene Tracey, Inaki F. Troconiz, Hans Van Niel, Jose Miguel Vela Hernandez, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Keith G. Phillips, Andrea Truini, Rolf-Detlef Treede
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-26 (2022)
Abstract Background IMI2-PainCare-BioPain-RCT2 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on specific compartments of the nociceptive system that could serve to accelerate the
Externí odkaz:
https://doaj.org/article/ee7c96a2132b40cebc8ecb1b9816874f
Autor:
Zahra Nochi, Hossein Pia, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Francesca Fardo, Bernd Genser, Marcus Goetz, Anna V. Kostenko, Caterina Leone, Thomas Li, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Alexandre Stouffs, Irene Tracey, Iñaki F. Troconiz, Andrea Truini, Johannes Van Niel, Jose Miguel Vela, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Hatice Tankisi, Nanna B. Finnerup, Keith G. Phillips, Rolf-Detlef Treede
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-20 (2022)
Abstract Background Few new drugs have been developed for chronic pain. Drug development is challenged by uncertainty about whether the drug engages the human target sufficiently to have a meaningful pharmacodynamic effect. IMI2-PainCare-BioPain-RCT1
Externí odkaz:
https://doaj.org/article/543fb202ce1b43b69a2ff64278b428c1
Publikováno v:
Veterinary Medicine and Science, Vol 8, Iss 1, Pp 31-45 (2022)
Abstract Enflicoxib is a newly developed NSAID of the coxib class. The optimal therapeutic dose to be confirmed in the field studies was established using a combination of pharmacokinetic (PK) modelling and pharmacodynamic (PD) studies. First, a PK s
Externí odkaz:
https://doaj.org/article/3964c3804fb44396812d9e5b21933afd
Autor:
André Mouraux, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Giulia Di Stefano, Nanna Brix Finnerup, Luis Garcia-Larrea, Marcus Goetz, Anna Kostenko, Bernhard Pelz, Esther Pogatzki-Zahn, Karin Schubart, Alexandre Stouffs, Andrea Truini, Irene Tracey, Iñaki F. Troconiz, Johannes Van Niel, Jose Miguel Vela, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Keith G. Phillips, Rolf-Detlef Treede
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-31 (2021)
Abstract Background IMI2-PainCare-BioPain-RCT3 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on the nociceptive system that could serve to accelerate the future development of an
Externí odkaz:
https://doaj.org/article/dbc3721db98f4427b854c0fc14ee978d
Autor:
Núria Gaja-Capdevila, Neus Hernández, Daniel Zamanillo, Jose Miguel Vela, Manuel Merlos, Xavier Navarro, Mireia Herrando-Grabulosa
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 6956 (2021)
Loss of motor neurons (MNs) after spinal root injury is a drawback limiting the recovery after palliative surgery by nerve or muscle transfers. Research based on preventing MN death is a hallmark to improve the perspectives of recovery following seve
Externí odkaz:
https://doaj.org/article/3ebd7658a98a49ba9fbf4f502a95edc9
Autor:
Juan Ramon Boyero, Jose Miguel Vela, Eva Wong, Carlos Garcia Ripoll, Maria Jesús Verdú, Alberto Urbaneja, Pilar Vanaclocha
Publikováno v:
Spanish Journal of Agricultural Research, Vol 12, Iss 1, Pp 244-251 (2014)
Parasitoids are the main natural enemies of the California red scale, Aonidiella aurantii (Maskell) and on occasion can regulate their populations. To increase their effectiveness, inoculative or augmentative releases of parasitoids are promoted. Pre
Externí odkaz:
https://doaj.org/article/0c01d867f21846ff9f4e8d44a9cb4339
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Caterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Nanna Brix Finnerup, Luis Garcia-Larrea, Tom Li, Marcus Goetz, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Irene Tracey, Inaki F. Troconiz, Hans Van Niel, Jose Miguel Vela Hernandez, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Keith G. Phillips, Andrea Truini, Rolf-Detlef Treede
Publikováno v:
Leone, C, Di Stefano, G, Di Pietro, G, Bloms-Funke, P, Boesl, I, Caspani, O, Chapman, S C, Finnerup, N B, Garcia-Larrea, L, Li, T, Goetz, M, Mouraux, A, Pelz, B, Pogatzki-Zahn, E, Schilder, A, Schnetter, E, Schubart, K, Tracey, I, Troconiz, I F, Van Niel, H, Hernandez, J M V, Vincent, K, Vollert, J, Wanigasekera, V, Wittayer, M, Phillips, K G, Truini, A & Treede, R D 2022, ' IMI2-PainCare-BioPain-RCT2 protocol : a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity ', Trials, vol. 23, no. 1, 739 . https://doi.org/10.1186/s13063-022-06431-5
Background IMI2-PainCare-BioPain-RCT2 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on specific compartments of the nociceptive system that could serve to accelerate the future d
Autor:
Katy Vincent, Marcus Goetz, Irene Tracey, Alexandre Stouffs, Matthias Wittayer, Giulia Di Stefano, Rolf-Detlef Treede, André Mouraux, Andrea Truini, Jose Miguel Vela, Esther M. Pogatzki-Zahn, Luis Garcia-Larrea, Johannes Van Niel, Irmgard Boesl, Anna Kostenko, Keith G. Phillips, Petra Bloms-Funke, Ombretta Caspani, Bernhard Pelz, Karin Schubart, Vishvarani Wanigasekera, Sonya C. Chapman, Iñaki F. Trocóniz, Nanna B. Finnerup, Jan Vollert
Publikováno v:
Trials
Mouraux, A, Bloms-Funke, P, Boesl, I, Caspani, O, Chapman, S C, Di Stefano, G, Finnerup, N B, Garcia-Larrea, L, Goetz, M, Kostenko, A, Pelz, B, Pogatzki-Zahn, E, Schubart, K, Stouffs, A, Truini, A, Tracey, I, Troconiz, I F, Van Niel, J, Vela, J M, Vincent, K, Vollert, J, Wanigasekera, V, Wittayer, M, Phillips, K G & Treede, R D 2021, ' IMI2-PainCare-BioPain-RCT3 : a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG) ', Trials, vol. 22, 404 . https://doi.org/10.1186/s13063-021-05272-y
Trials, Vol 22, Iss 1, Pp 1-31 (2021)
Mouraux, A, Bloms-Funke, P, Boesl, I, Caspani, O, Chapman, S C, Di Stefano, G, Finnerup, N B, Garcia-Larrea, L, Goetz, M, Kostenko, A, Pelz, B, Pogatzki-Zahn, E, Schubart, K, Stouffs, A, Truini, A, Tracey, I, Troconiz, I F, Van Niel, J, Vela, J M, Vincent, K, Vollert, J, Wanigasekera, V, Wittayer, M, Phillips, K G & Treede, R D 2021, ' IMI2-PainCare-BioPain-RCT3 : a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG) ', Trials, vol. 22, 404 . https://doi.org/10.1186/s13063-021-05272-y
Trials, Vol 22, Iss 1, Pp 1-31 (2021)
Background IMI2-PainCare-BioPain-RCT3 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on the nociceptive system that could serve to accelerate the future development of analgesics,